| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $177.5M | +9.6% |
| Cost of Revenue | $163.0M | +7.7% |
| Gross Profit | $14.5M | +36.4% |
| R&D Expense | $1.5M | — |
| SG&A Expense | $35.6M | -14.9% |
| Operating Income | -$28.6M | +31.0% |
| Pre-tax Income | -$31.7M | +26.9% |
| Income Tax | $2.0M | +37.0% |
| Net Income | -$33.7M | +25.9% |
| EPS (Basic) | -$1.30 | +31.6% |
| EPS (Diluted) | -$1.30 | +31.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.5M | -63.8% |
| Accounts Receivable | $22.7M | +0.4% |
| Inventory | $29.0M | +24.7% |
| Current Assets | $82.0M | -2.5% |
| Total Assets | $231.1M | +1.3% |
| Current Liabilities | $189.7M | +9.1% |
| Long-term Debt | $7.0M | -46.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.0M | +41.9% |
| Investing Cash Flow | -$8.2M | +8.0% |
| Financing Cash Flow | $17.3M | -6.1% |
| Total Liabilities |
| $213.2M |
| +5.5% |
| Stockholders' Equity | $12.2M | -45.6% |